ENTRY       D06399            Mixture   Drug
NAME        Tegafur, gimeracil and oteracil potassium;
            Ts-1 (TN);
            Teysuno (TN)
COMPONENT   Tegafur [DR:D01244], Gimeracil [DR:D01846], Potassium 2,6-dihydroxytriazinecarboxylate [CPD:C15997]
REMARK      Therapeutic category: 4229
            ATC code: L01BC53
            Product: D06399<JP>
EFFICACY    Antineoplastic, Antimetabolite
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC53 Tegafur, combinations
                  D06399  Tegafur, gimeracil and oteracil potassium &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4229  Others
                 D06399  Tegafur, gimeracil and oteracil potassium
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06399
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D06399
DBLINKS     PubChem: 47208056
///
